Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for SANA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 164.68M
March 31, 2026 105.33M
December 31, 2025 142.58M
September 30, 2025 157.25M
June 30, 2025 76.87M
March 31, 2025 108.90M
December 31, 2024 156.33M
September 30, 2024 202.84M
June 30, 2024 255.48M
March 31, 2024 314.91M
December 31, 2023 209.03M
September 30, 2023 272.40M
June 30, 2023 332.02M
March 31, 2023 355.41M
Date Value
December 31, 2022 430.06M
September 30, 2022 491.85M
June 30, 2022 484.80M
March 31, 2022 512.38M
December 31, 2021 551.00M
September 30, 2021 603.71M
June 30, 2021 852.84M
March 31, 2021 960.24M
December 31, 2020 378.26M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 138.98M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 166.84M
Beam Therapeutics, Inc. 1.153B
Prime Medicine, Inc. 95.07M
Intellia Therapeutics, Inc. 437.76M
Moderna, Inc. 5.138B